These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11589917)

  • 1. Platelet amyloid precursor protein forms in AD: a peripheral diagnostic tool and a pharmacological target.
    Padovani A; Borroni B; Colciaghi F; Pastorino L; Archetti S; Cottini E; Caimi L; Cattabeni F; Di Luca M
    Mech Ageing Dev; 2001 Nov; 122(16):1997-2004. PubMed ID: 11589917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ApoE genotype influences the biological effect of donepezil on APP metabolism in Alzheimer disease: evidence from a peripheral model.
    Borroni B; Colciaghi F; Pastorino L; Archetti S; Corsini P; Cattabeni F; Di Luca M; Padovani A
    Eur Neuropsychopharmacol; 2002 Jun; 12(3):195-200. PubMed ID: 12007670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloid precursor protein in platelets of patients with Alzheimer disease: effect of acetylcholinesterase inhibitor treatment.
    Borroni B; Colciaghi F; Pastorino L; Pettenati C; Cottini E; Rozzini L; Monastero R; Lenzi GL; Cattabeni F; Di Luca M; Padovani A
    Arch Neurol; 2001 Mar; 58(3):442-6. PubMed ID: 11255448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein Expression of BACE1 is Downregulated by Donepezil in Alzheimer's Disease Platelets.
    Sarno TA; Talib LL; Joaquim HP; Bram JM; Gattaz WF; Forlenza OV
    J Alzheimers Dis; 2017; 55(4):1445-1451. PubMed ID: 27858713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloid precursor protein in platelets: a peripheral marker for the diagnosis of sporadic AD.
    Padovani A; Pastorino L; Borroni B; Colciaghi F; Rozzini L; Monastero R; Perez J; Pettenati C; Mussi M; Parrinello G; Cottini E; Lenzi GL; Trabucchi M; Cattabeni F; Di Luca M
    Neurology; 2001 Dec; 57(12):2243-8. PubMed ID: 11756604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early stages of probable Alzheimer disease are associated with changes in platelet amyloid precursor protein forms.
    Borroni B; Colciaghi F; Corsini P; Akkawi N; Rozzini L; Del Zotto E; Talarico G; Cattabeni F; Lenzi GL; Di Luca M; Padovani A
    Neurol Sci; 2002 Dec; 23(5):207-10. PubMed ID: 12522675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced platelet amyloid precursor protein ratio (APP ratio) predicts conversion from mild cognitive impairment to Alzheimer's disease.
    Zainaghi IA; Talib LL; Diniz BS; Gattaz WF; Forlenza OV
    J Neural Transm (Vienna); 2012 Jul; 119(7):815-9. PubMed ID: 22573143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential level of platelet amyloid beta precursor protein isoforms: an early marker for Alzheimer disease.
    Di Luca M; Pastorino L; Bianchetti A; Perez J; Vignolo LA; Lenzi GL; Trabucchi M; Cattabeni F; Padovani A
    Arch Neurol; 1998 Sep; 55(9):1195-200. PubMed ID: 9740113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelets as a peripheral district where to study pathogenetic mechanisms of alzheimer disease: the case of amyloid precursor protein.
    Di Luca M; Colciaghi F; Pastorino L; Borroni B; Padovani A; Cattabeni F
    Eur J Pharmacol; 2000 Sep; 405(1-3):277-83. PubMed ID: 11033334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased iPLA2 activity and levels of phosphorylated GSK3B in platelets are associated with donepezil treatment in Alzheimer's disease patients.
    Talib LL; Hototian SR; Joaquim HP; Forlenza OV; Gattaz WF
    Eur Arch Psychiatry Clin Neurosci; 2015 Dec; 265(8):701-6. PubMed ID: 25920742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of donepezil treatment on platelets α and β secretase activities in Alzheimer's disease patients].
    Dong GS; Li X; Jiang QH; Yang HQ
    Zhonghua Yi Xue Za Zhi; 2011 Dec; 91(47):3341-5. PubMed ID: 22333201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet amyloid precursor protein processing: a bio-marker for Alzheimer's disease.
    Tang K; Hynan LS; Baskin F; Rosenberg RN
    J Neurol Sci; 2006 Jan; 240(1-2):53-8. PubMed ID: 16256140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloid precursor protein expression is enhanced in human platelets from subjects with Alzheimer's disease and frontotemporal lobar degeneration: a real-time PCR study.
    Vignini A; Morganti S; Salvolini E; Sartini D; Luzzi S; Fiorini R; Provinciali L; Di Primio R; Mazzanti L; Emanuelli M
    Exp Gerontol; 2013 Dec; 48(12):1505-8. PubMed ID: 24400342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet APP isoform ratios correlate with declining cognition in AD.
    Baskin F; Rosenberg RN; Iyer L; Hynan L; Cullum CM
    Neurology; 2000 May; 54(10):1907-9. PubMed ID: 10822427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet dysfunction in hypercholesterolemia mice, two Alzheimer's disease mouse models and in human patients with Alzheimer's disease.
    Plagg B; Marksteiner J; Kniewallner KM; Humpel C
    Biogerontology; 2015 Aug; 16(4):543-58. PubMed ID: 25947203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormalities in the pattern of platelet amyloid precursor protein forms in patients with mild cognitive impairment and Alzheimer disease.
    Padovani A; Borroni B; Colciaghi F; Pettenati C; Cottini E; Agosti C; Lenzi GL; Caltagirone C; Trabucchi M; Cattabeni F; Di Luca M
    Arch Neurol; 2002 Jan; 59(1):71-5. PubMed ID: 11790233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between platelet amyloid precursor protein isoform ratio and cognition in Alzheimer's disease.
    Liu HC; Wang HC; Ko SY; Wang PN; Chi CW; Hong CJ; Lin KN; Liu TY
    J Alzheimers Dis; 2007 Mar; 11(1):77-84. PubMed ID: 17361037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal platelet amyloid-β protein precursor (AβPP) metabolism in Alzheimer's disease: identification and characterization of a new AβPP isoform as potential biomarker.
    Jelic V; Hagman G; Yamamoto NG; Teranishi Y; Nishimura T; Winblad B; Pavlov PF
    J Alzheimers Dis; 2013; 35(2):285-95. PubMed ID: 23388171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholinesterase inhibitors influence APP metabolism in Alzheimer disease patients.
    Zimmermann M; Borroni B; Cattabeni F; Padovani A; Di Luca M
    Neurobiol Dis; 2005; 19(1-2):237-42. PubMed ID: 15837579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The platelet amyloid precursor protein ratio as a diagnostic marker for Alzheimer's disease in Thai patients.
    Srisawat C; Junnu S; Peerapittayamongkol C; Futrakul A; Soi-ampornkul R; Senanarong V; Praditsuwan R; Assantachai P; Neungton N
    J Clin Neurosci; 2013 May; 20(5):644-8. PubMed ID: 23453155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.